RecruitingPhase 3NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Sponsor: Eli Lilly and Company
Hartford, CT · +10 more sites
5 recruiting crohn's disease studies with a site in Hartford, CT.
Sponsor: Eli Lilly and Company
Hartford, CT · +10 more sites
Sponsor: Eli Lilly and Company
Hartford, CT · +14 more sites
Sponsor: Janssen Research & Development, LLC
Hartford, CT · +13 more sites
Sponsor: Connecticut Children's Medical Center
Hartford, CT
Sponsor: Connecticut Children's Medical Center
Hartford, CT · +21 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.